MYCELX Technologies Corporation (AIM:MYX)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 10.96M |
| Revenue (ttm) | 2.24M |
| Net Income (ttm) | -2.39M |
| Shares Out | 24.36M |
| EPS (ttm) | -0.10 |
| PE Ratio | n/a |
| Forward PE | 58.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26 |
| Average Volume | 6,728 |
| Open | 45.00 |
| Previous Close | 45.00 |
| Day's Range | 43.00 - 47.00 |
| 52-Week Range | 18.25 - 48.40 |
| Beta | 1.32 |
| RSI | 54.02 |
| Earnings Date | May 13, 2026 |
About MYCELX Technologies
MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the PFAS remediation and produced water markets in the Middle East, the United States, Australia, and internationally. The company also sells and leases its equipment; and sells filtration media. It serves the oil and gas, power, marine, and heavy manufacturing sectors. The company was incorporated in 1994 and is headquartered in Norcross, Georgia. [Read more]
Financial Performance
In 2024, MYCELX Technologies's revenue was $4.90 million, a decrease of -55.05% compared to the previous year's $10.91 million. Losses were -$2.72 million, -26.52% less than in 2023.
Financial numbers in USD Financial StatementsNews
AIM Market Roundup: Trellus Health, Genedrive, Mycelx
Trellus Health, Genedrive, Mycelx are today's top risers, while CPP, PetroTal take the biggest fall on London's AIM market
Mycelx expects drilling boom to fuel growth
Mycelx Technologies is well positioned to benefit from growth in the US oil drilling sector and potential from new multi-billion PFAS industry